Table 2.
Endpoint in the analysis | No. of THAs |
No. of revisions |
10–year survival a |
RR b | 95% CI c | p–value |
---|---|---|---|---|---|---|
Any reason for revision | 302,838 | 12,067 | ||||
Pediatric hip disease | 14,403 | 853 | 93.6% | 1.04 | 0.96–1.12 | 0.4 |
Primary osteoarthritis | 288 435 | 11,214 | 93.8% | 1 | – | – |
Aseptic loosening | 302 838 | 5,803 | ||||
Pediatric hip disease | 14,403 | 396 | 97.2% | 1.00 | 0.89–1.11 | 1.0 |
Primary osteoarthritis | 288 435 | 5,407 | 97.0% | 1 | – | – |
Dislocation | 302 838 | 2,641 | ||||
Pediatric hip disease | 14,403 | 156 | 98.7% | 1.10 | 0.92–1.31 | 0.3 |
Primary osteoarthritis | 288 435 | 2,485 | 98.8% | 1 | – | – |
– | ||||||
Infection | 302 838 | 1,806 | ||||
Pediatric hip disease | 14,403 | 72 | 99.3% | 0.86 | 0.67–1.10 | 0.2 |
Primary osteoarthritis | 288 435 | 1,734 | 99.3% | 1 | – | – |
a Cox–adjusted 10–year survival.
b Cox relative revision risk.
c 95% confidence interval for RR.